Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations . Rev Diabet Stud. 2023;6(1). Accessed April 3, 2026. https://diabeticstudies.org/index.php/RDS/article/view/252